# Plasmapheresis Before Rituximab in Cryoglobulinemia

> **NCT04692363** · — · UNKNOWN · sponsor: **University Hospital, Montpellier** · enrollment: 120 (estimated)

## Conditions studied

- Cryoglobulinemic Vasculitis

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT04692363
- **Lead sponsor:** University Hospital, Montpellier
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 1999-01-01
- **Primary completion:** 2021-12-01
- **Final completion:** 2021-12-31
- **Target enrollment:** 120 (ESTIMATED)
- **Last updated:** 2020-12-31


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04692363

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04692363, "Plasmapheresis Before Rituximab in Cryoglobulinemia". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04692363. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*